nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—Doxorubicin—peripheral nervous system neoplasm	0.288	0.414	CbGbCtD
L-Arginine—NOS2—Doxorubicin—peripheral nervous system neoplasm	0.288	0.414	CbGbCtD
L-Arginine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.12	0.173	CbGbCtD
L-Arginine—NOS2—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.0196	0.176	CbGpPWpGaD
L-Arginine—NOS3—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.0152	0.136	CbGpPWpGaD
L-Arginine—Brain oedema—Isotretinoin—peripheral nervous system neoplasm	0.0074	0.0405	CcSEcCtD
L-Arginine—Brain oedema—Tretinoin—peripheral nervous system neoplasm	0.0074	0.0405	CcSEcCtD
L-Arginine—Skin necrosis—Melphalan—peripheral nervous system neoplasm	0.00598	0.0327	CcSEcCtD
L-Arginine—Brain oedema—Alitretinoin—peripheral nervous system neoplasm	0.00561	0.0307	CcSEcCtD
L-Arginine—Skin necrosis—Cisplatin—peripheral nervous system neoplasm	0.00391	0.0214	CcSEcCtD
L-Arginine—Skin necrosis—Etoposide—peripheral nervous system neoplasm	0.00358	0.0196	CcSEcCtD
L-Arginine—NOS3—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.00271	0.0243	CbGpPWpGaD
L-Arginine—Numbness—Isotretinoin—peripheral nervous system neoplasm	0.00255	0.0139	CcSEcCtD
L-Arginine—Numbness—Tretinoin—peripheral nervous system neoplasm	0.00255	0.0139	CcSEcCtD
L-Arginine—Extravasation—Topotecan—peripheral nervous system neoplasm	0.00244	0.0134	CcSEcCtD
L-Arginine—Sensory loss—Tretinoin—peripheral nervous system neoplasm	0.00244	0.0133	CcSEcCtD
L-Arginine—Sensory loss—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.0133	CcSEcCtD
L-Arginine—Extravasation—Melphalan—peripheral nervous system neoplasm	0.00239	0.0131	CcSEcCtD
L-Arginine—NOS3—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.00224	0.0201	CbGpPWpGaD
L-Arginine—Necrosis—Dactinomycin—peripheral nervous system neoplasm	0.0022	0.012	CcSEcCtD
L-Arginine—Injection site reaction—Tretinoin—peripheral nervous system neoplasm	0.0021	0.0115	CcSEcCtD
L-Arginine—Injection site reaction—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.0115	CcSEcCtD
L-Arginine—Injection site reaction—Melphalan—peripheral nervous system neoplasm	0.00208	0.0113	CcSEcCtD
L-Arginine—Skin exfoliation—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.011	CcSEcCtD
L-Arginine—Skin exfoliation—Tretinoin—peripheral nervous system neoplasm	0.00202	0.011	CcSEcCtD
L-Arginine—Skin necrosis—Epirubicin—peripheral nervous system neoplasm	0.00201	0.011	CcSEcCtD
L-Arginine—Skin exfoliation—Melphalan—peripheral nervous system neoplasm	0.00199	0.0109	CcSEcCtD
L-Arginine—Extravasation—Dactinomycin—peripheral nervous system neoplasm	0.00198	0.0108	CcSEcCtD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.00198	0.0177	CbGpPWpGaD
L-Arginine—Numbness—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.0106	CcSEcCtD
L-Arginine—Numbness—Vincristine—peripheral nervous system neoplasm	0.00186	0.0102	CcSEcCtD
L-Arginine—Skin necrosis—Doxorubicin—peripheral nervous system neoplasm	0.00186	0.0102	CcSEcCtD
L-Arginine—Sensory loss—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.0101	CcSEcCtD
L-Arginine—Sensory loss—Vincristine—peripheral nervous system neoplasm	0.00178	0.00975	CcSEcCtD
L-Arginine—Extravasation—Vincristine—peripheral nervous system neoplasm	0.00177	0.00968	CcSEcCtD
L-Arginine—AZIN2—trigeminal ganglion—peripheral nervous system neoplasm	0.00174	0.182	CbGeAlD
L-Arginine—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00951	CcSEcCtD
L-Arginine—Swelling—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00951	CcSEcCtD
L-Arginine—Necrosis—Cisplatin—peripheral nervous system neoplasm	0.00174	0.00951	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.00173	0.0154	CbGpPWpGaD
L-Arginine—NOS2—Type II interferon signaling (IFNG)—IFNB1—peripheral nervous system neoplasm	0.00167	0.015	CbGpPWpGaD
L-Arginine—Necrosis—Etoposide—peripheral nervous system neoplasm	0.00159	0.00872	CcSEcCtD
L-Arginine—Injection site reaction—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00871	CcSEcCtD
L-Arginine—Lethargy—Topotecan—peripheral nervous system neoplasm	0.00158	0.00863	CcSEcCtD
L-Arginine—Lethargy—Tretinoin—peripheral nervous system neoplasm	0.00157	0.00857	CcSEcCtD
L-Arginine—Lethargy—Isotretinoin—peripheral nervous system neoplasm	0.00157	0.00857	CcSEcCtD
L-Arginine—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00856	CcSEcCtD
L-Arginine—AZIN2—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00154	0.0138	CbGpPWpGaD
L-Arginine—Skin exfoliation—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00837	CcSEcCtD
L-Arginine—Numbness—Etoposide—peripheral nervous system neoplasm	0.00151	0.00825	CcSEcCtD
L-Arginine—Sensory loss—Etoposide—peripheral nervous system neoplasm	0.00144	0.0079	CcSEcCtD
L-Arginine—Extravasation—Etoposide—peripheral nervous system neoplasm	0.00143	0.00784	CcSEcCtD
L-Arginine—ASL—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00141	0.0126	CbGpPWpGaD
L-Arginine—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00721	CcSEcCtD
L-Arginine—Skin exfoliation—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00713	CcSEcCtD
L-Arginine—Lethargy—Dactinomycin—peripheral nervous system neoplasm	0.00128	0.007	CcSEcCtD
L-Arginine—AZIN2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0012	0.0107	CbGpPWpGaD
L-Arginine—Skin exfoliation—Etoposide—peripheral nervous system neoplasm	0.0012	0.00653	CcSEcCtD
L-Arginine—Lethargy—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00649	CcSEcCtD
L-Arginine—ARG2—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00116	0.0104	CbGpPWpGaD
L-Arginine—NOS3—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	0.00115	0.0103	CbGpPWpGaD
L-Arginine—Sweating—Topotecan—peripheral nervous system neoplasm	0.00114	0.00625	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.00114	0.0102	CbGpPWpGaD
L-Arginine—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.0062	CcSEcCtD
L-Arginine—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00113	0.0062	CcSEcCtD
L-Arginine—Haematuria—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00617	CcSEcCtD
L-Arginine—Haematuria—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00617	CcSEcCtD
L-Arginine—ASL—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0011	0.00983	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Topotecan—peripheral nervous system neoplasm	0.00107	0.00582	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.00106	0.00949	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00578	CcSEcCtD
L-Arginine—Hypoaesthesia—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00578	CcSEcCtD
L-Arginine—Swelling—Etoposide—peripheral nervous system neoplasm	0.00103	0.00563	CcSEcCtD
L-Arginine—Flushing—Tretinoin—peripheral nervous system neoplasm	0.000986	0.00539	CcSEcCtD
L-Arginine—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.000986	0.00539	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NTRK2—peripheral nervous system neoplasm	0.000982	0.00879	CbGpPWpGaD
L-Arginine—Flushing—Melphalan—peripheral nervous system neoplasm	0.000973	0.00532	CcSEcCtD
L-Arginine—NOS2—Type II interferon signaling (IFNG)—PTPN11—peripheral nervous system neoplasm	0.000942	0.00843	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00091	0.00814	CbGpPWpGaD
L-Arginine—ARG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000909	0.0946	CbGeAlD
L-Arginine—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.000894	0.00489	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—PTPN11—peripheral nervous system neoplasm	0.000889	0.00796	CbGpPWpGaD
L-Arginine—NOS3—eNOS activation—AKT1—peripheral nervous system neoplasm	0.00088	0.00788	CbGpPWpGaD
L-Arginine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00086	0.0047	CcSEcCtD
L-Arginine—ARG2—parotid gland—peripheral nervous system neoplasm	0.000857	0.0893	CbGeAlD
L-Arginine—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.000855	0.00467	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000837	0.00749	CbGpPWpGaD
L-Arginine—Sweating—Vincristine—peripheral nervous system neoplasm	0.000829	0.00453	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.000827	0.00452	CcSEcCtD
L-Arginine—AZIN2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000811	0.00726	CbGpPWpGaD
L-Arginine—ASS1—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.000807	0.00722	CbGpPWpGaD
L-Arginine—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000806	0.0044	CcSEcCtD
L-Arginine—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.000804	0.00439	CcSEcCtD
L-Arginine—ARG2—brainstem—peripheral nervous system neoplasm	0.000804	0.0837	CbGeAlD
L-Arginine—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000801	0.00438	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NTRK1—peripheral nervous system neoplasm	0.000801	0.00717	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	0.000784	0.00702	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000772	0.00422	CcSEcCtD
L-Arginine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000761	0.00416	CcSEcCtD
L-Arginine—AZIN2—cerebellum—peripheral nervous system neoplasm	0.000761	0.0792	CbGeAlD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—COX2—peripheral nervous system neoplasm	0.000759	0.00679	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000755	0.00413	CcSEcCtD
L-Arginine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000755	0.00413	CcSEcCtD
L-Arginine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000747	0.00408	CcSEcCtD
L-Arginine—NOS2—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.000747	0.00668	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000745	0.00407	CcSEcCtD
L-Arginine—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.000744	0.00407	CcSEcCtD
L-Arginine—ASL—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000741	0.00664	CbGpPWpGaD
L-Arginine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000737	0.00403	CcSEcCtD
L-Arginine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000737	0.00403	CcSEcCtD
L-Arginine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000736	0.00402	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—BDNF—peripheral nervous system neoplasm	0.000733	0.00656	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—BIRC5—peripheral nervous system neoplasm	0.000731	0.00654	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00073	0.00399	CcSEcCtD
L-Arginine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00073	0.00399	CcSEcCtD
L-Arginine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000727	0.00397	CcSEcCtD
L-Arginine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000725	0.00396	CcSEcCtD
L-Arginine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00072	0.00393	CcSEcCtD
L-Arginine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00072	0.00393	CcSEcCtD
L-Arginine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00071	0.00388	CcSEcCtD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000709	0.00634	CbGpPWpGaD
L-Arginine—ASL—cerebellum—peripheral nervous system neoplasm	0.000707	0.0737	CbGeAlD
L-Arginine—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—peripheral nervous system neoplasm	0.000699	0.00626	CbGpPWpGaD
L-Arginine—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.000698	0.00381	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000681	0.00609	CbGpPWpGaD
L-Arginine—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00067	0.00366	CcSEcCtD
L-Arginine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000662	0.00362	CcSEcCtD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000659	0.0059	CbGpPWpGaD
L-Arginine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000656	0.00359	CcSEcCtD
L-Arginine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000656	0.00359	CcSEcCtD
L-Arginine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000648	0.00354	CcSEcCtD
L-Arginine—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.00353	CcSEcCtD
L-Arginine—ASS1—trigeminal ganglion—peripheral nervous system neoplasm	0.000637	0.0663	CbGeAlD
L-Arginine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000637	0.00348	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000633	0.00566	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00063	0.00564	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000625	0.00342	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.00062	0.00339	CcSEcCtD
L-Arginine—ARG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000614	0.0055	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—peripheral nervous system neoplasm	0.000605	0.00541	CbGpPWpGaD
L-Arginine—ASS1—parotid gland—peripheral nervous system neoplasm	0.000601	0.0626	CbGeAlD
L-Arginine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000588	0.00321	CcSEcCtD
L-Arginine—AZIN2—Metabolism—GNS—peripheral nervous system neoplasm	0.000586	0.00525	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—PTPN11—peripheral nervous system neoplasm	0.000586	0.00524	CbGpPWpGaD
L-Arginine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000583	0.00319	CcSEcCtD
L-Arginine—NOS3—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.00058	0.00519	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—PTPN11—peripheral nervous system neoplasm	0.000575	0.00515	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000572	0.00313	CcSEcCtD
L-Arginine—AZIN2—Metabolism—NME1—peripheral nervous system neoplasm	0.000562	0.00503	CbGpPWpGaD
L-Arginine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000561	0.00306	CcSEcCtD
L-Arginine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.00305	CcSEcCtD
L-Arginine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000556	0.00304	CcSEcCtD
L-Arginine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000556	0.00304	CcSEcCtD
L-Arginine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.00302	CcSEcCtD
L-Arginine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000551	0.00301	CcSEcCtD
L-Arginine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000549	0.003	CcSEcCtD
L-Arginine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.00298	CcSEcCtD
L-Arginine—AZIN2—Metabolism—COX2—peripheral nervous system neoplasm	0.000541	0.00484	CbGpPWpGaD
L-Arginine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000536	0.00293	CcSEcCtD
L-Arginine—ASL—Metabolism—GNS—peripheral nervous system neoplasm	0.000536	0.0048	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000535	0.00479	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000533	0.00291	CcSEcCtD
L-Arginine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000525	0.00287	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.00052	0.00284	CcSEcCtD
L-Arginine—NOS2—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.000519	0.00464	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NME1—peripheral nervous system neoplasm	0.000514	0.0046	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—PTPN11—peripheral nervous system neoplasm	0.000511	0.00457	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000508	0.00455	CbGpPWpGaD
L-Arginine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000497	0.00272	CcSEcCtD
L-Arginine—ASL—Metabolism—COX2—peripheral nervous system neoplasm	0.000495	0.00443	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000487	0.00266	CcSEcCtD
L-Arginine—NOS3—Metabolism of nitric oxide—AKT1—peripheral nervous system neoplasm	0.000484	0.00433	CbGpPWpGaD
L-Arginine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000484	0.00264	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.00263	CcSEcCtD
L-Arginine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00048	0.00262	CcSEcCtD
L-Arginine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00048	0.00262	CcSEcCtD
L-Arginine—Rash—Topotecan—peripheral nervous system neoplasm	0.00048	0.00262	CcSEcCtD
L-Arginine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000479	0.00262	CcSEcCtD
L-Arginine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000479	0.00262	CcSEcCtD
L-Arginine—Headache—Topotecan—peripheral nervous system neoplasm	0.000477	0.00261	CcSEcCtD
L-Arginine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000476	0.0026	CcSEcCtD
L-Arginine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000476	0.0026	CcSEcCtD
L-Arginine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000476	0.0026	CcSEcCtD
L-Arginine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000476	0.0026	CcSEcCtD
L-Arginine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000476	0.0026	CcSEcCtD
L-Arginine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000474	0.00259	CcSEcCtD
L-Arginine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000473	0.00258	CcSEcCtD
L-Arginine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000473	0.00258	CcSEcCtD
L-Arginine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000471	0.00258	CcSEcCtD
L-Arginine—Rash—Melphalan—peripheral nervous system neoplasm	0.00047	0.00257	CcSEcCtD
L-Arginine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000469	0.00257	CcSEcCtD
L-Arginine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000465	0.00254	CcSEcCtD
L-Arginine—SLC7A1—cerebellum—peripheral nervous system neoplasm	0.000464	0.0483	CbGeAlD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—peripheral nervous system neoplasm	0.000463	0.00414	CbGpPWpGaD
L-Arginine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000455	0.00248	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000453	0.00406	CbGpPWpGaD
L-Arginine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000452	0.00247	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—PTPN11—peripheral nervous system neoplasm	0.00045	0.00402	CbGpPWpGaD
L-Arginine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000448	0.00245	CcSEcCtD
L-Arginine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000448	0.00245	CcSEcCtD
L-Arginine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000447	0.00244	CcSEcCtD
L-Arginine—ARG2—Metabolism—GNS—peripheral nervous system neoplasm	0.000444	0.00398	CbGpPWpGaD
L-Arginine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000443	0.00242	CcSEcCtD
L-Arginine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000436	0.00238	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AURKA—peripheral nervous system neoplasm	0.000432	0.00387	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000432	0.00236	CcSEcCtD
L-Arginine—SLC16A10—parotid gland—peripheral nervous system neoplasm	0.000429	0.0447	CbGeAlD
L-Arginine—NOS2—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000429	0.00384	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000426	0.00381	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NME1—peripheral nervous system neoplasm	0.000426	0.00381	CbGpPWpGaD
L-Arginine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000426	0.00233	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	0.000425	0.00381	CbGpPWpGaD
L-Arginine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000424	0.00232	CcSEcCtD
L-Arginine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.0023	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000416	0.00372	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—COX2—peripheral nervous system neoplasm	0.00041	0.00367	CbGpPWpGaD
L-Arginine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000406	0.00222	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000405	0.00363	CbGpPWpGaD
L-Arginine—NOS3—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.000403	0.00361	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—AKT1—peripheral nervous system neoplasm	0.000402	0.0036	CbGpPWpGaD
L-Arginine—ARG2—cerebellum—peripheral nervous system neoplasm	0.000396	0.0413	CbGeAlD
L-Arginine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000392	0.00214	CcSEcCtD
L-Arginine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000389	0.00213	CcSEcCtD
L-Arginine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000388	0.00212	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000382	0.00342	CbGpPWpGaD
L-Arginine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000376	0.00206	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000374	0.00205	CcSEcCtD
L-Arginine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000367	0.002	CcSEcCtD
L-Arginine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000364	0.00199	CcSEcCtD
L-Arginine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.00197	CcSEcCtD
L-Arginine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00197	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00036	0.00322	CbGpPWpGaD
L-Arginine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000359	0.00196	CcSEcCtD
L-Arginine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.00196	CcSEcCtD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—AKT1—peripheral nervous system neoplasm	0.000355	0.00318	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000355	0.00318	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—peripheral nervous system neoplasm	0.000352	0.00315	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000351	0.00192	CcSEcCtD
L-Arginine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000351	0.00192	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.0019	CcSEcCtD
L-Arginine—Rash—Vincristine—peripheral nervous system neoplasm	0.000348	0.0019	CcSEcCtD
L-Arginine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000347	0.0019	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.00189	CcSEcCtD
L-Arginine—Headache—Vincristine—peripheral nervous system neoplasm	0.000345	0.00189	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—AKT1—peripheral nervous system neoplasm	0.000345	0.00309	CbGpPWpGaD
L-Arginine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.00186	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000335	0.003	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.000335	0.003	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	0.00033	0.00296	CbGpPWpGaD
L-Arginine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000329	0.0018	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.000329	0.00294	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—peripheral nervous system neoplasm	0.000328	0.00294	CbGpPWpGaD
L-Arginine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000327	0.00179	CcSEcCtD
L-Arginine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000327	0.00179	CcSEcCtD
L-Arginine—ASL—Metabolism—ENO2—peripheral nervous system neoplasm	0.000325	0.00291	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.00177	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—PTPN11—peripheral nervous system neoplasm	0.000313	0.0028	CbGpPWpGaD
L-Arginine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00031	0.00169	CcSEcCtD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000309	0.00276	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GNS—peripheral nervous system neoplasm	0.000308	0.00276	CbGpPWpGaD
L-Arginine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000307	0.00168	CcSEcCtD
L-Arginine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000307	0.00168	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NRAS—peripheral nervous system neoplasm	0.000307	0.00275	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000304	0.00272	CbGpPWpGaD
L-Arginine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.00165	CcSEcCtD
L-Arginine—AZIN2—Metabolism—BCHE—peripheral nervous system neoplasm	0.0003	0.00269	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000296	0.00265	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000296	0.00265	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—PTPN11—peripheral nervous system neoplasm	0.000295	0.00264	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NME1—peripheral nervous system neoplasm	0.000295	0.00264	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000291	0.00261	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00029	0.00259	CbGpPWpGaD
L-Arginine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00029	0.00158	CcSEcCtD
L-Arginine—AZIN2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000286	0.00256	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000284	0.00255	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—COX2—peripheral nervous system neoplasm	0.000284	0.00254	CbGpPWpGaD
L-Arginine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000284	0.00155	CcSEcCtD
L-Arginine—AZIN2—Metabolism—TH—peripheral nervous system neoplasm	0.000282	0.00253	CbGpPWpGaD
L-Arginine—Rash—Etoposide—peripheral nervous system neoplasm	0.000282	0.00154	CcSEcCtD
L-Arginine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000281	0.00154	CcSEcCtD
L-Arginine—Headache—Etoposide—peripheral nervous system neoplasm	0.00028	0.00153	CcSEcCtD
L-Arginine—ASS1—cerebellum—peripheral nervous system neoplasm	0.000278	0.0289	CbGeAlD
L-Arginine—NOS3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000274	0.00246	CbGpPWpGaD
L-Arginine—ASL—Metabolism—BCHE—peripheral nervous system neoplasm	0.000274	0.00246	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—peripheral nervous system neoplasm	0.000269	0.00241	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000269	0.00241	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000269	0.00241	CbGpPWpGaD
L-Arginine—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	0.000268	0.0279	CbGeAlD
L-Arginine—NOS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000267	0.00239	CbGpPWpGaD
L-Arginine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000265	0.00145	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000264	0.00237	CbGpPWpGaD
L-Arginine—ASL—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000262	0.00234	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000262	0.00234	CbGpPWpGaD
L-Arginine—ASL—Metabolism—TH—peripheral nervous system neoplasm	0.000258	0.00231	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—peripheral nervous system neoplasm	0.000258	0.00231	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000253	0.00227	CbGpPWpGaD
L-Arginine—SLC22A5—parotid gland—peripheral nervous system neoplasm	0.000253	0.0263	CbGeAlD
L-Arginine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00137	CcSEcCtD
L-Arginine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00134	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00132	CcSEcCtD
L-Arginine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.0013	CcSEcCtD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000232	0.00208	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00127	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.00023	0.00206	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.00023	0.00206	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GNAS—peripheral nervous system neoplasm	0.00023	0.00206	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—peripheral nervous system neoplasm	0.000228	0.00204	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000227	0.00204	CbGpPWpGaD
L-Arginine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00124	CcSEcCtD
L-Arginine—AZIN2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000226	0.00202	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—peripheral nervous system neoplasm	0.000225	0.00201	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.000224	0.00201	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00122	CcSEcCtD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000223	0.002	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000223	0.00199	CbGpPWpGaD
L-Arginine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00121	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00119	CcSEcCtD
L-Arginine—ARG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000217	0.00194	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TH—peripheral nervous system neoplasm	0.000214	0.00191	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GNAS—peripheral nervous system neoplasm	0.000211	0.00189	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000209	0.00187	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000207	0.00185	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000206	0.00185	CbGpPWpGaD
L-Arginine—NOS2—Disease—GNS—peripheral nervous system neoplasm	0.000206	0.00184	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—AKT1—peripheral nervous system neoplasm	0.000204	0.00183	CbGpPWpGaD
L-Arginine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.0011	CcSEcCtD
L-Arginine—SLC16A10—cerebellum—peripheral nervous system neoplasm	0.000198	0.0207	CbGeAlD
L-Arginine—NOS2—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000191	0.00171	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—peripheral nervous system neoplasm	0.000188	0.00168	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000187	0.00167	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000185	0.00166	CbGpPWpGaD
L-Arginine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00101	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000183	0.00164	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.000179	0.0016	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—NRAS—peripheral nervous system neoplasm	0.000178	0.00159	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ERBB2—peripheral nervous system neoplasm	0.000177	0.00159	CbGpPWpGaD
L-Arginine—SLC22A4—cerebellum—peripheral nervous system neoplasm	0.000177	0.0184	CbGeAlD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—peripheral nervous system neoplasm	0.000175	0.00156	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000175	0.00156	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000171	0.00153	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000171	0.00153	CbGpPWpGaD
L-Arginine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000933	CcSEcCtD
L-Arginine—NOS2—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000167	0.0015	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000161	0.00145	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00016	0.00143	CbGpPWpGaD
L-Arginine—NOS3—Disease—GNS—peripheral nervous system neoplasm	0.00016	0.00143	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HGF—peripheral nervous system neoplasm	0.000159	0.00143	CbGpPWpGaD
L-Arginine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00087	CcSEcCtD
L-Arginine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000863	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000862	CcSEcCtD
L-Arginine—ASS1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000158	0.00141	CbGpPWpGaD
L-Arginine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000857	CcSEcCtD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000157	0.0014	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000154	0.00138	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00015	0.00135	CbGpPWpGaD
L-Arginine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000813	CcSEcCtD
L-Arginine—NOS3—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000149	0.00133	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TH—peripheral nervous system neoplasm	0.000148	0.00133	CbGpPWpGaD
L-Arginine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000805	CcSEcCtD
L-Arginine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000798	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000797	CcSEcCtD
L-Arginine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000793	CcSEcCtD
L-Arginine—NOS2—Disease—PPP3R1—peripheral nervous system neoplasm	0.000144	0.00129	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	0.000138	0.00123	CbGpPWpGaD
L-Arginine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000752	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000137	0.00123	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNS—peripheral nervous system neoplasm	0.000134	0.0012	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	0.00013	0.00116	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00013	0.00116	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NME1—peripheral nervous system neoplasm	0.000128	0.00115	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000126	0.00113	CbGpPWpGaD
L-Arginine—NOS2—Disease—ENO2—peripheral nervous system neoplasm	0.000125	0.00112	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000124	0.00111	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000124	0.00111	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HGF—peripheral nervous system neoplasm	0.000124	0.00111	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—COX2—peripheral nervous system neoplasm	0.000124	0.00111	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000122	0.00109	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	0.000122	0.00109	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000121	0.00108	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000119	0.00106	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000118	0.00105	CbGpPWpGaD
L-Arginine—SLC22A5—cerebellum—peripheral nervous system neoplasm	0.000117	0.0122	CbGeAlD
L-Arginine—NOS2—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000116	0.00104	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	0.000115	0.00103	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000112	0.001	CbGpPWpGaD
L-Arginine—NOS3—Disease—PPP3R1—peripheral nervous system neoplasm	0.000112	0.001	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000112	0.001	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000107	0.000962	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC2A1—peripheral nervous system neoplasm	0.000101	0.000901	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	9.87e-05	0.000884	CbGpPWpGaD
L-Arginine—NOS3—Disease—ENO2—peripheral nervous system neoplasm	9.7e-05	0.000868	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.48e-05	0.000849	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.3e-05	0.000833	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PTPN11—peripheral nervous system neoplasm	9.03e-05	0.000808	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	8.72e-05	0.00078	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VIP—peripheral nervous system neoplasm	8.49e-05	0.00076	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ENO2—peripheral nervous system neoplasm	8.12e-05	0.000727	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.84e-05	0.000702	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC2A1—peripheral nervous system neoplasm	7.81e-05	0.0007	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—peripheral nervous system neoplasm	6.99e-05	0.000626	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—BCHE—peripheral nervous system neoplasm	6.86e-05	0.000614	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.54e-05	0.000586	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TH—peripheral nervous system neoplasm	6.45e-05	0.000577	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—peripheral nervous system neoplasm	6.22e-05	0.000556	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.89e-05	0.000527	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—peripheral nervous system neoplasm	5.69e-05	0.000509	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTPN11—peripheral nervous system neoplasm	5.63e-05	0.000504	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—peripheral nervous system neoplasm	5.43e-05	0.000486	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—peripheral nervous system neoplasm	5.35e-05	0.000479	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNAS—peripheral nervous system neoplasm	5.27e-05	0.000471	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCB1—peripheral nervous system neoplasm	5.17e-05	0.000463	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—peripheral nervous system neoplasm	5.11e-05	0.000458	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.04e-05	0.000451	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.8e-05	0.00043	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—peripheral nervous system neoplasm	4.71e-05	0.000422	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—peripheral nervous system neoplasm	4.51e-05	0.000404	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—peripheral nervous system neoplasm	4.45e-05	0.000398	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.4e-05	0.000394	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTPN11—peripheral nervous system neoplasm	4.37e-05	0.000391	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—peripheral nervous system neoplasm	4.15e-05	0.000372	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—peripheral nervous system neoplasm	3.97e-05	0.000355	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—peripheral nervous system neoplasm	3.51e-05	0.000314	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—peripheral nervous system neoplasm	3.45e-05	0.000309	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—peripheral nervous system neoplasm	3.38e-05	0.000303	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—peripheral nervous system neoplasm	3.27e-05	0.000292	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—peripheral nervous system neoplasm	3.15e-05	0.000282	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.06e-05	0.000274	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—peripheral nervous system neoplasm	2.63e-05	0.000235	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—peripheral nervous system neoplasm	2.48e-05	0.000222	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—peripheral nervous system neoplasm	2.45e-05	0.000219	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.42e-05	0.000216	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.2e-05	0.000196	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—peripheral nervous system neoplasm	2.19e-05	0.000196	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—peripheral nervous system neoplasm	1.92e-05	0.000172	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.84e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.71e-05	0.000153	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—peripheral nervous system neoplasm	1.7e-05	0.000152	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—peripheral nervous system neoplasm	1.42e-05	0.000127	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.41e-05	0.000126	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.35e-05	0.00012	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000106	CbGpPWpGaD
